Author(s)

Edward Shi

East Ridge High School, Woodbury, MN, USA.

Neuropsychiatric diseases, including ADHD, schizophrenia, and bipolar disorder, are increasingly prevalent but poorly understood at the molecular level. The complexities of diagnosing and treating these disorders emphasize the need for objective, quantitative data to improve diagnostic accuracy and treatment efficacy. This study aims to explore the genetic underpinnings of neuropsychiatric diseases, contrasting them with well-characterized diseases like breast cancer, and discuss the role of specific genetic mutations and their implications for personalized treatment. The paper delves into the genetic and molecular insights of neuropsychiatric diseases, examining the role of specific genetic mutations and the potential for gene editing technologies like CRISPR. It contrasts the genetic underpinnings of neuropsychiatric diseases with well-characterized diseases like breast cancer, highlighting the potential for a shift towards molecular and genetic-based diagnostics and treatments. The study argues that a shift towards molecular and genetic-based diagnostics and treatments could revolutionize our approach to neuropsychiatric diseases, much like how biomarker tests have transformed breast cancer treatment. It concludes by advocating for a more personalized approach to healthcare, tailored to an individual’s unique genetic makeup, as the future of neuropsychiatric disease diagnosis and treatment.

Neuropsychiatric Diseases, ADHD, Huntington’s Disease, Molecular Biology, Genetics

Shi, E. (2023) Advancing Neuropsychiatric Care through Genetic and Molecular Insights. Journal of Biosciences and Medicines, 11, 191-199. doi: 10.4236/jbm.2023.1110018.